In presentation slides to be used by representatives of STAAR Surgical to give presentations to investors commencing on March 14, the company repeats its FY23 sales outlook of $340.0M, which represents 26% growth and was previously provided on January 9 and reaffirmed on February 21.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on STAA: